Biotech Not Cratering, Just Deflating
Biotech Not Cratering, Just Deflating
To see where the biotech sector is headed tomorrow, it might be helpful for investors to look back, and more importantly, forget about, the recent past.
Cuba seeks new drug markets
Cuba seeks new drug markets
Inside modern towers that are a pride of Fidel Castro, scientists peer through huge microscopes at tiny proteins they hope to tailor to treat such major killers as AIDS, heart disease and cancer.
Time to Let the Air Out
Time to Let the Air Out
If you think biotech stocks are headed for a breakout anytime soon, allow us to burst your bubble
FDA rules need tweaking
FDA rules need tweaking
The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments